Format

Send to

Choose Destination
Autoimmunity. 2015 May;48(3):152-60. doi: 10.3109/08916934.2014.1003641. Epub 2015 Feb 16.

Vaccination to modulate atherosclerosis.

Author information

1
Division of Inflammation Biology and.

Abstract

Atherosclerosis is a chronic inflammatory disease of the artery wall. Adaptive immunity plays a key role in the pathogenesis of atherosclerosis. Recently, modulation of the immune response against atherosclerotic plaque antigen(s) has attracted attention as a potentially preventive and therapeutic approach. Here, we review a series of studies on immunization with various antigens targeting treatment and prevention of atherosclerosis. Atherosclerosis-related antigens include oxidized low-density lipoprotein (LDL), apolipoprotein B-100 (ApoB-100) and heat shock protein (HSP) 60/65. Accumulating evidence supports the idea that immunization with these antigenic proteins or peptides may reduce atherosclerosis. In this review, we discuss the current status of immunization studies and possible associated mechanisms of atheroprotection.

KEYWORDS:

Apolipoprotein B-100; atherosclerosis; heat shock protein 65; immunization; low-density lipoprotein

PMID:
25683179
PMCID:
PMC4429861
DOI:
10.3109/08916934.2014.1003641
[Indexed for MEDLINE]
Free PMC Article

Supplemental Content

Full text links

Icon for Taylor & Francis Icon for PubMed Central
Loading ...
Support Center